Secondary prevention for stroke and transient ischaemic attacks

BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7444.896-b (Published 08 April 2004) Cite this as: BMJ 2004;328:896

PROGRESS is about reducing blood pressure, not promoting drugs

  1. Martin Duerden, general practitioner (martin@theduerdens.co.uk)
  1. Meddygfa Gyffin, Conwy, North Wales LL32 8LT

    EDITOR—In his editorial Muir argues for the combination of perindopril and indapamide as preferred agents for lowering blood pressure after stroke or transient ischaemic attack on the basis of the perindopril protection against recurrent stroke study (PROGRESS).1 Is this justified? PROGRESS did not compare regimens; other evidence shows that lowering blood pressure …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription